(RDN) Radian - Overview
Sector: Financial Services | Industry: Insurance - Specialty | Exchange: NYSE (USA) | Market Cap: 4.831m USD | Total Return: 3.8% in 12m
Avg Turnover: 40.4M
EPS Trend: 60.4%
Qual. Beats: 0
Rev. Trend: 68.5%
Qual. Beats: 1
Warnings
Below Avwap Earnings
Tailwinds
Confidence
Radian Group Inc. (RDN) is a Pennsylvania-based financial services firm specializing in mortgage insurance and risk management for the U.S. residential housing market. The company protects mortgage lenders and investors against credit losses by providing private mortgage insurance (PMI) on first-lien residential loans, alongside specialty insurance and reinsurance products.
The business model relies on credit risk aggregation, where Radian assumes a portion of the default risk in exchange for premium payments, typically required when a borrower’s down payment is less than 20%. As a key participant in the mortgage finance sector, Radian facilitates liquidity in the primary housing market by enabling low-down-payment lending for commercial banks, credit unions, and mortgage originators. Investors should examine ValueRay for deeper insights into the companys valuation metrics.
Founded in 1977, Radian operates within a highly regulated industry where capital adequacy requirements are governed by the Private Mortgage Insurer Eligibility Requirements (PMIERs). This regulatory framework ensures that firms maintain sufficient liquid assets to pay claims during periods of elevated mortgage defaults or economic downturns.
- New mortgage originations volume drives primary insurance in force growth
- Persistently high interest rates suppress refinancing activity and premium turnover
- Low mortgage default rates minimize provision for losses and boost margins
- Federal Housing Administration pricing changes impact private mortgage insurance market share
- Credit risk transfer strategies optimize capital efficiency and drive shareholder returns
| Net Income: 562.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 10.63 > 1.0 |
| NWC/Revenue: -57.11% < 20% (prev 523.2%; Δ -580.3% < -1%) |
| CFO/TA 0.03 > 3% & CFO 337.1m > Net Income 562.3m |
| Net Debt (1.09b) to EBITDA (784.3m): 1.39 < 3 |
| Current Ratio: 0.49 > 1.5 & < 3 |
| Outstanding Shares: last quarter (138.5m) vs 12m ago -6.26% < -2% |
| Gross Margin: 87.56% > 18% (prev 0.93%; Δ 8.66k% > 0.5%) |
| Asset Turnover: 14.65% > 50% (prev 14.55%; Δ 0.10% > 0%) |
| Interest Coverage Ratio: 9.32 > 6 (EBITDA TTM 784.3m / Interest Expense TTM 80.3m) |
| A: -0.08 (Total Current Assets 753.9m - Total Current Liabilities 1.55b) / Total Assets 10.3b |
| B: 0.51 (Retained Earnings 5.22b / Total Assets 10.3b) |
| C: 0.08 (EBIT TTM 748.4m / Avg Total Assets 9.53b) |
| D: 0.90 (Book Value of Equity 4.96b / Total Liabilities 5.49b) |
| Altman-Z'' = 2.62 = A |
| DSRI: 3.62 (Receivables 665.9m/168.0m, Revenue 1.40b/1.28b) |
| GMI: 1.07 (GM 87.56% / 93.43%) |
| AQI: 4.22 (AQ_t 0.92 / AQ_t-1 0.22) |
| SGI: 1.09 (Revenue 1.40b / 1.28b) |
| TATA: 0.02 (NI 562.3m - CFO 337.1m) / TA 10.3b) |
| Beneish M = 1.19 (Cap -4..+1) = D |
As of June 01, 2026, the stock is trading at USD 34.15 with a total of 824,376 shares traded.
Over the past week, the price has changed by -8.22%,
over one month by -4.69%,
over three months by -2.29% and
over the past year by +3.82%.
Radian has received a consensus analysts rating of 3.50. Therefore, it is recommended to hold RDN.
- StrongBuy: 1
- Buy: 2
- Hold: 2
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 43.2 | 26.4% |
P/E Trailing = 8.4685
P/E Forward = 7.2674
P/S = 3.525
P/B = 1.0045
P/EG = 0.7588
Revenue TTM = 1.40b USD
EBIT TTM = 748.4m USD
EBITDA TTM = 784.3m USD
Long Term Debt = 1.08b USD (from longTermDebt, last quarter)
Short Term Debt = 494.7m USD (from shortTermDebt, last quarter)
Debt = 1.18b USD (from shortLongTermDebtTotal, last quarter) + Leases 33.4m
Net Debt = 1.09b USD (calculated: Debt 1.18b - CCE 88.0m)
Enterprise Value = 5.92b USD (4.83b + Debt 1.18b - CCE 88.0m)
Interest Coverage Ratio = 9.32 (Ebit TTM 748.4m / Interest Expense TTM 80.3m)
EV/FCF = 17.77x (Enterprise Value 5.92b / FCF TTM 333.3m)
FCF Yield = 5.63% (FCF TTM 333.3m / Enterprise Value 5.92b)
FCF Margin = 23.88% (FCF TTM 333.3m / Revenue TTM 1.40b)
Net Margin = 40.28% (Net Income TTM 562.3m / Revenue TTM 1.40b)
Gross Margin = 87.56% ((Revenue TTM 1.40b - Cost of Revenue TTM 173.7m) / Revenue TTM)
Gross Margin QoQ = 76.86% (prev none%)
Tobins Q-Ratio = 0.58 (Enterprise Value 5.92b / Total Assets 10.3b)
Interest Expense / Debt = 6.80% (Interest Expense 80.3m / Debt 1.18b)
Taxrate = 25.45% (44.2m / 173.7m)
NOPAT = 557.9m (EBIT 748.4m * (1 - 25.45%))
Current Ratio = 0.49 (Total Current Assets 753.9m / Total Current Liabilities 1.55b)
Debt / Equity = 0.25 (Debt 1.18b / totalStockholderEquity, last quarter 4.81b)
Debt / EBITDA = 1.39 (Net Debt 1.09b / EBITDA 784.3m)
Debt / FCF = 3.28 (Net Debt 1.09b / FCF TTM 333.3m)
Total Stockholder Equity = 4.68b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.90% (Net Income 562.3m / Total Assets 10.3b)
RoE = 12.01% (Net Income TTM 562.3m / Total Stockholder Equity 4.68b)
RoCE = 12.99% (EBIT 748.4m / Capital Employed (Equity 4.68b + L.T.Debt 1.08b))
RoIC = 6.10% (NOPAT 557.9m / Invested Capital 9.15b)
WACC = 7.49% (E(4.83b)/V(6.01b) * Re(8.08%) + D(1.18b)/V(6.01b) * Rd(6.80%) * (1-Tc(0.25)))
Discount Rate = 8.08% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -82.22 | Cagr: -5.49%
[DCF] Terminal Value 75.44% ; FCFF base≈333.3m ; Y1≈334.7m ; Y5≈354.6m
[DCF] Fair Price = 33.25 (EV 5.51b - Net Debt 1.09b = Equity 4.42b / Shares 133.0m; r=8.35% [WACC [floored]]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: 60.42 | EPS CAGR: 2.48% | SUE: 0.51 | # QB: 0
Revenue Correlation: 68.52 | Revenue CAGR: 2.75% | SUE: 1.51 | # QB: 1
EPS current Quarter (2026-06-30): EPS=1.36 | Chg30d=+9.08% | Revisions=+33% | Analysts=4
EPS next Quarter (2026-09-30): EPS=1.35 | Chg30d=+8.47% | Revisions=+33% | Analysts=4
EPS current Year (2026-12-31): EPS=5.32 | Chg30d=+7.55% | Revisions=+33% | GrowthEPS=+26.6% | GrowthRev=+78.8%
EPS next Year (2027-12-31): EPS=5.49 | Chg30d=+1.95% | Revisions=+20% | GrowthEPS=+3.2% | GrowthRev=-16.7%
[Analyst] Revisions Ratio: +33%